ارتباط بین دوز تابش تجمعی، واکنش های پوستی و تغییرات سطح هموگلوبین در زنان تحت درمان با حفظ پستان

HSI demonstrates promise in the assessment of skin dose as well as an objective measure of skin reaction. The ability to easily identify adverse skin reactions and to modify the treatment plan may circumvent the need for detrimental treatment breaks.